Inspired by Nature, Enabled by Science
Raised to Date: Raised: $48,152
Rolling Commitments ($USD)
% of Min. Goal
% of Max. Goal
Likelihood of Max
Avg. Daily Raise
Healthcare & Pharmaceuticals
Aphios Pharma LLC is exploring how to best leverage, develop, and commercialize cannabis-based drugs for Central Nervous System (CNS) and other disorders. To accomplish this, Aphios Pharma “...utilizes supercritical fluid technologies to improve drug discovery, manufacturing, and formulation in a sustainable, environmentally-friendly manner.” They manufacture pharmaceutical-grade pure natural cannabinoids that both follow cGMP guidelines of the FDA and are in compliance with the Drug Enforcement Agency (DEA). So far, their work has led to endeavors that are likely to advance the science of cannabinoid-based medicines -- as well as make significant contributions to science and medicine.
Upgrade to gain access
Annually (Save 17%)
- Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
- Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.